VERACYTE, INC. Quarterly Costs and Expenses in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Veracyte, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2015 to Q3 2024.
  • Veracyte, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $67M, a 25.1% decline year-over-year.
  • Veracyte, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $442M, a 33.3% increase year-over-year.
  • Veracyte, Inc. annual Costs and Expenses for 2023 was $447M, a 32.4% increase from 2022.
  • Veracyte, Inc. annual Costs and Expenses for 2022 was $338M, a 12% increase from 2021.
  • Veracyte, Inc. annual Costs and Expenses for 2021 was $301M, a 97.2% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $442M $67M -$22.4M -25.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $465M $73.3M +$9.44M +14.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $455M $102M +$8.58M +9.23% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $447M $201M +$115M +134% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $332M $89.4M +$4.15M +4.87% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $328M $63.9M -$19.7M -23.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $348M $92.9M +$9.89M +11.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $338M $85.7M +$6.05M +7.59% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $332M $85.3M +$8.22M +10.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $323M $83.6M +$21M +33.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $302M $83M +$913K +1.11% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $301M $79.7M +$37.1M +87% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $264M $77.1M +$41.9M +119% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $222M $62.6M +$30.8M +97.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $192M $82.1M +$38.8M +89.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $153M $42.6M +$4.68M +12.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $148M $35.2M +$2.45M +7.49% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $146M $31.8M -$1.48M -4.46% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-29
Q1 2020 $147M $43.3M +$11.7M +37.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $135M $37.9M +$9.12M +31.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $126M $32.7M +$4.97M +17.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $121M $33.2M +$4.57M +15.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-30
Q1 2019 $117M $31.6M +$2.6M +8.97% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $114M $28.8M +$3.17M +12.4% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-22
Q3 2018 $111M $27.8M +$3.88M +16.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-22
Q2 2018 $107M $28.7M +$3.65M +14.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-30
Q1 2018 $104M $29M +$5.05M +21.1% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-30
Q4 2017 $98.5M $25.6M Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $23.9M +$398K +1.69% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 $25M -$154K -0.61% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-23
Q1 2017 $23.9M +$648K +2.78% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q3 2016 $23.5M +$2.27M +10.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 $25.2M +$4.19M +20% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-31
Q1 2016 $23.3M +$4.53M +24.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q3 2015 $21.2M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $21M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $18.8M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.